Manufacturer:

Athenex Pharmaceuticals

Name:

MIDAZOLAM HCL

Category:

J Code

HCPCS:

J2250

NDC(s):

00409-2305-05, 00409-2305-17, 00409-2305-50, 00409-2308-01, 00409-2308-02, 00409-2308-49, 00409-2308-50, 00409-2587-05, 00409-2596-03, 00409-2596-05, 00641-6056-10, 00641-6057-25, 00641-6059-10, 00641-6060-10, 00641-6061-25, 00641-6063-25, 00641-6190-10, 00641-6209-25, 00641-6210-10, 00641-6211-10, 23155-0600-41, 23155-0601-41, 23155-0601-42, 47781-0588-68, 47781-0589-91, 57664-0633-43, 57664-0634-45, 63323-0411-10, 63323-0411-12, 63323-0411-25, 63323-0412-02, 63323-0412-05, 63323-0412-10, 63323-0412-25, 70860-0600-02, 70860-0601-05, 70860-0601-10, 72572-0430-25, 72572-0432-10, 72611-0741-25, 72611-0749-10, 76045-0001-20, 76045-0002-10, 76045-0003-20, 17478-0524-10,

Primary Type:

benzodiazepine

Route of Administration:

Injection

About:

MIDAZOLAM HCL is a benzodiazepine drug manufactured by Athenex Pharmaceuticals and administered via the Injection route of administration. The J Code: J2250 is aligned to the drug MIDAZOLAM HCL.